Pfizer看到Mitchell Sinkler & Starr PA和普罗维登斯财富顾问的股权在Q1的强劲结果中增加。 Pfizer saw increased stakes from Mitchell Sinkler & Starr PA and Providence Wealth Advisors amid strong Q1 results.

投资公司Mitchell Sinkler & Starr PA在2022年Q1中将Pfizer公司的股份增加了2.1%,持有量价值742,000美元。 Investment firm Mitchell Sinkler & Starr PA increased its stake in Pfizer Inc. by 2.1% in Q1 2022, with holdings worth $742,000. 普罗维登斯财富顾问有限责任公司也将其在辉瑞公司持有的股份提高了2.1%,拥有42 217股,价值1 039 000美元。 Providence Wealth Advisors LLC also raised its holdings in Pfizer by 2.1%, owning 42,217 shares worth $1,039,000. Pfizer报告有一个强大的Q1, EPS为0.92美元,超过估计数25美元,并产生137.2亿美元的收入。 Pfizer reported a strong Q1, with an EPS of $0.92, exceeding estimates by $0.25, and generated $13.72 billion in revenue. 该公司在各种治疗领域提供产品,最近宣布季度红利为0.43美元。 The company offers products in various therapeutic areas and recently declared a quarterly dividend of $0.43.